Skip to content

Author

D. Shanehbandi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

Targeting lncRNA PVT1/miR‐145‐5p/ABCC‐1 Pathway Enhances Paclitaxel Sensitivity and Suppresses Melanoma Progression

Background As a highly aggressive type of skin cancer, melanoma cells show significant resistance against a variety of chemotherapeutics, such as paclitaxel, which limits the efficacy of the treatment. Studies have highlighted the potential role of noncoding RNA dysregulation in melanoma, affecting tumor progression an...

Negar Pedram, R. Safaralizadeh, M. Feizi et al. · 0 citations
Review Sep 2026

Targeting interrelated NLRP3 and NF-κβ signaling pathways to develop enhanced tolerogenic dendritic cells: Promising prospect for autoimmune disorders.

Proper immune response needs a regulated interaction between adaptive and innate immunity and dendritic cells (DCs) as professional antigen presenting cells coordinate their interaction. In order to maintain the balance between tolerance and initiation of immune response, these DCs should be activated in a regulated ma...

Shiva Alipour, Amirhossein Mardi, D. Shanehbandi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.